BML, Inc. (BMLKF)
OTCMKTS · Delayed Price · Currency is USD
24.10
-0.86 (-3.45%)
At close: Jan 8, 2026

BML, Inc. Company Description

BML, Inc. provides contract clinical testing and related services in Japan.

The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing.

It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds.

In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services.

The company was incorporated in 1955 and is headquartered in Tokyo, Japan.

BML, Inc.
CountryJapan
Founded1955
IndustryDiagnostics & Research
SectorHealthcare
Employees4,558
CEOKensuke Kondo

Contact Details

Address:
5-21-3 Sendagaya
Tokyo, 151-0051
Japan
Phone81 3 3350 0111
Websitebml.co.jp

Stock Details

Ticker SymbolBMLKF
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
SIC Code8731

Key Executives

NamePosition
Kensuke KondoPresident and Representative Director
Norihisa TakebeRepresentative Director, Senior Managing Executive Officer and Head of Planning and Sales Division
Nobuki AraiVice President and Representative Director
Hideaki OsawaExec Officer, Dir of Sales Div, Director of Pharmaceutical Clinical Trial Sales Dept and Director
Masami KondoExecutive Officer
Kenji ShibataExecutive Officer and Director
Yuji YamashitaExecutive Officer, Head of Systems Division and Director
Hiroyuki KigoshiManaging Executive Officer
Yuji YamashitaExecutive Officer and Director